Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Jackson

Showing results (31-40 of 251) with videos related to

Pageof 26
Sort By:
Primary Health Care Research & Development|August 9, 2011
A qualitative study exploring why people do not participate in cardiac rehabilitation and coronary heart disease self-help groups, and their rehabilitation experience without these resourcesAngela Mary Jackson, Brian McKinstry, Susan Gregory, et al.
Protein Expression and Purification|May 10, 2014
Purification and characterization of the acyltransferase involved in biosynthesis of the major mycobacterial cell envelope glycolipid--monoacylated phosphatidylinositol dimannosideZuzana Svetlíková, Peter Baráth, Mary Jackson, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 2008
N-D-aldopentofuranosyl-N'-[p-(isoamyloxy)phenyl]-thiourea derivatives: potential anti-TB therapeutic agentsAvraham Liav, Shiva K Angala, Patrick J Brennan, et al.
Nature Chemical Biology|February 15, 2018
Covalent modifications of polysaccharides in mycobacteriaShiva K Angala, Zuzana Palčeková, Juan M Belardinelli, et al.
Healthcare Quarterly (Toronto, Ont.)|April 24, 2015
Optimizing learning in healthcare: how Island Health is evolving to learn at the speed of changeConrad Gottfredson, Carol Stroud, Mary Jackson, et al.
International Journal of Molecular Sciences|September 2, 2020
MmpL3 Inhibition: A New Approach to Treat Nontuberculous Mycobacterial InfectionsJigar P Sethiya, Melanie A Sowards, Mary Jackson, et al.
Expert Opinion on Drug Discovery|May 25, 2023
Recent advances in mycobacterial membrane protein large 3 inhibitor drug design for mycobacterial infectionsE Jeffrey North, Chris P Schwartz, Helen I Zgurskaya, et al.
Chest|May 12, 2004
Sputum dysplasia, related to bacterial load, oxidative stress, and airway inflammation in COPDPhilip E Silkoff, Ashley Busacker, John Trudeau, et al.
Infection Control and Hospital Epidemiology|May 3, 2017
Disinfectant Susceptibility Profiling of Glutaraldehyde-Resistant Nontuberculous MycobacteriaWinona Burgess, Alyssa Margolis, Sara Gibbs, et al.
American Journal of Infection Control|February 14, 2012
Aldehyde-resistant mycobacteria bacteria associated with the use of endoscope reprocessing systemsChristopher W Fisher, Anthony Fiorello, Diana Shaffer, et al.
Pageof 26

Showing results (31-40 of 251) with videos related to

Sort By:
Pageof 26
Primary Health Care Research & Development|August 9, 2011
A qualitative study exploring why people do not participate in cardiac rehabilitation and coronary heart disease self-help groups, and their rehabilitation experience without these resourcesAngela Mary Jackson, Brian McKinstry, Susan Gregory, et al.
Protein Expression and Purification|May 10, 2014
Purification and characterization of the acyltransferase involved in biosynthesis of the major mycobacterial cell envelope glycolipid--monoacylated phosphatidylinositol dimannosideZuzana Svetlíková, Peter Baráth, Mary Jackson, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 2008
N-D-aldopentofuranosyl-N'-[p-(isoamyloxy)phenyl]-thiourea derivatives: potential anti-TB therapeutic agentsAvraham Liav, Shiva K Angala, Patrick J Brennan, et al.
Nature Chemical Biology|February 15, 2018
Covalent modifications of polysaccharides in mycobacteriaShiva K Angala, Zuzana Palčeková, Juan M Belardinelli, et al.
Healthcare Quarterly (Toronto, Ont.)|April 24, 2015
Optimizing learning in healthcare: how Island Health is evolving to learn at the speed of changeConrad Gottfredson, Carol Stroud, Mary Jackson, et al.
International Journal of Molecular Sciences|September 2, 2020
MmpL3 Inhibition: A New Approach to Treat Nontuberculous Mycobacterial InfectionsJigar P Sethiya, Melanie A Sowards, Mary Jackson, et al.
Expert Opinion on Drug Discovery|May 25, 2023
Recent advances in mycobacterial membrane protein large 3 inhibitor drug design for mycobacterial infectionsE Jeffrey North, Chris P Schwartz, Helen I Zgurskaya, et al.
Chest|May 12, 2004
Sputum dysplasia, related to bacterial load, oxidative stress, and airway inflammation in COPDPhilip E Silkoff, Ashley Busacker, John Trudeau, et al.
Infection Control and Hospital Epidemiology|May 3, 2017
Disinfectant Susceptibility Profiling of Glutaraldehyde-Resistant Nontuberculous MycobacteriaWinona Burgess, Alyssa Margolis, Sara Gibbs, et al.
American Journal of Infection Control|February 14, 2012
Aldehyde-resistant mycobacteria bacteria associated with the use of endoscope reprocessing systemsChristopher W Fisher, Anthony Fiorello, Diana Shaffer, et al.
Pageof 26